Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
RAB18
REST API REST API
Homo sapiens
RAB18 is differentially expressed in 206 experiments: 104 organism parts: bone marrow, cerebellum, ... (102 more);, 88 disease states: normal, Huntington's disease, ... (86 more);, 77 cell types 329 cell lines 25 compound treatments and 59 other conditions.
Orthologs Rab18 (Mus musculus)   RAB18_BOVIN (Bos taurus)   RAB18_CHICK (Gallus gallus)   rab18b (Danio rerio)   rab18a (Danio rerio)   Rab18 (Rattus norvegicus)   F7AG83_CIOIN (Ciona intestinalis)   Rab-RP4 (Drosophila melanogaster)   rab18 (Xenopus laevis)   RAB18 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term plasma membrane, GTPase activity, regulation of transcription, DNA-dependent, cytoplasm, intracellular, membrane, intracellular protein transport, transcription factor binding, GTP catabolic process, GTP binding, ATP binding, small GTPase mediated signal transduction, nucleus, nucleotide binding, nucleocytoplasmic transport, signal transduction, protein transport, endocytosis
InterPro Term Gtr1_RagA, Ran_GTPase, MIRO-like, ProtSyn_GTP-bd, Small_GTPase, Small_GTP-bd_dom, Small_GTPase_ARF, Small_GTPase_ARF/SAR, Small_GTPase_Ras, Small_GTPase_Rho, Small_GTPase_Rab_type
UniProt Accession Q9NP72, Q5W0I9, Q5W0J0, B7Z333, F5H4U3
Gene-Disease Assocation WARBURG MICRO SYNDROME 3; WARBM3
Search EB-eye ENSG00000099246
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-6573, E-GEOD-22541, E-GEOD-6919, E-GEOD-26672, ... (16 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-19639, E-GEOD-4219, E-GEOD-3202, E-GEOD-19466, ... (26 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-19639, E-GEOD-5823, E-GEOD-20081
LNCaP
2
E-GEOD-14990, E-GEOD-14464
U87
2
E-GEOD-20089, E-MEXP-903
YCC11
1
E-GEOD-15460
GM19099
1
E-GEOD-19466
HEL9217
1
E-MTAB-37
323 more value(s).


Cell type

studied in E-TABM-40, E-GEOD-22373, E-GEOD-21668, E-GEOD-20677, E-GEOD-13909, ... (34 experiments)

Factor Value U/D Experiments
hematopoietic stem cell
1
E-MEXP-1403
dendritic cell-derived osteoclast
1
E-MEXP-2019
human foreskin fibroblast
1
E-GEOD-18265
activated natural killer cell (supplemented for IL2 for 2 hours)
1
E-TABM-702
induced pluripotent stem cell
1
E-GEOD-18147
1
1
E-TABM-130
71 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-MEXP-2069, E-MEXP-1121, ... (40 experiments)

Factor Value U/D Experiments
Huntington's disease
2
E-GEOD-3790, E-AFMX-6
benign prostatic hyperplasia
2
E-MEXP-2034, E-MEXP-1243
glioblastoma
2
E-GEOD-4290, E-GEOD-4412
prostate carcinoma
2
E-MEXP-2034, E-GEOD-7307
uterine fibroid
1
E-GEOD-7307
viral hemorrhagic fever
1
E-GEOD-12254
82 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-5741, E-TABM-782, E-GEOD-5099, E-GEOD-15811, ... (17 experiments)

Factor Value U/D Experiments
ox-LDL
1
E-GEOD-5741
unknown
1
E-GEOD-7307
eicosapentaenoic acid
1
E-MEXP-1389
no estradiol
1
E-GEOD-20081
gamma-secretase inhibitor DAPT
1
E-GEOD-6495
estradiol
1
E-GEOD-20081
19 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

crosslinker and crosslinking wavelength
studied in E-GEOD-21918

Developmental stage
studied in E-GEOD-20033, E-MEXP-2359, E-GEOD-4667

Dfs follow up
studied in E-GEOD-22541

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-3325, E-GEOD-22148, E-MEXP-2280, ... (7 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-4086

Estrogen receptor status
studied in E-GEOD-6532

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-6207, E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, ... (9 experiments)

Genotype
studied in E-GEOD-22056, E-GEOD-17476, E-TABM-868, E-TABM-601, E-MEXP-1838, ... (7 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-GEOD-7011, E-MEXP-2657, E-TABM-127, E-GEOD-20540, E-GEOD-20504, ... (9 experiments)

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-MEXP-1648, E-TABM-118, ... (26 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-GEOD-17400

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Phenotype
studied in E-GEOD-26495, E-GEOD-1460, E-GEOD-17636, E-MEXP-1403

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791, E-GEOD-10896

Rna integrity
studied in E-TABM-325

RNAi
studied in E-MEXP-2115, E-MEXP-1857, E-MEXP-875

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-17400, E-GEOD-18995

Sex
studied in E-GEOD-1643, E-TABM-311, E-GEOD-7307

Sirna
studied in E-GEOD-21575, E-GEOD-21574

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-13818, E-GEOD-12198 ... (5 experiments)

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271

Tumor size
studied in E-GEOD-4922

Processing time: 0.291 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM